Rua Bioscience Limited — Share Issue/Capital Change 2020

Oct 22, 2020

==> picture [101 x 49] intentionally omitted <==

Section 1: Issuer information
Name of issuer	Rua Bioscience Limited
NZX ticker code	RUA
Class of financial product	Ordinary shares
ISIN	NZRUAE0004S1
Currency	NZD
Section 2: Capital change details
Number issued	40,000,000 ordinary shares issued under Rua Bioscience Limited’s initial public offering
Nominal value (if any)	Not applicable
Issue price per security	$0.50
Nature of the payment (for example, cash or other consideration)	Cash
Amount paid up (if not in full)	Not applicable
Percentage of total class of Financial Products issued (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence)	28.569% of the total number of ordinary shares on issue
For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date)	Not applicable
Reason for issue and specific authority for issue (the reason for change must be identified here)	Allotment of ordinary shares under the initial public offering of ordinary shares in Rua Bioscience Limited
Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption.	140,012,225 ordinary shares
In the case of an acquisition of shares, whether those shares are to be held as treasury stock	Not applicable
Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made	Board resolutions dated 24 September 2020

Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements)	The ordinary shares will rank equally in all respects with existing ordinary shares of Rua Bioscience Limited at the date on which they are issued. For further details see the product disclosure statement for the initial public offering of ordinary shares in Rua Bioscience Limited dated 25 September 2020
Date of issue	21 October 2020
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement	Rob Mitchell, Chief Executive Officer of Rua Bioscience Limited
Contact person for this announcement	Rob Mitchell
Contact phone number	+64 9 309 5840
Contact email address	Rob.mitchell@ruabio.com
Date of release through MAP	22 October 2020